DiaSorin S.p.A. (BIT:DIA)
Italy
· Delayed Price · Currency is EUR 95.38
-1.42 (-1.47%)
May 9, 2025, 5:35 PM CET
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Italy Operating Profit | 104.56M |
Log In |
Log In |
Log In |
Log In |
| Italy Operating Profit Growth | -37.72% |
Log In |
Log In |
Log In |
Log In |
| Europe Operating Profit | 24.35M |
Log In |
Log In |
Log In |
Log In |
| Europe Operating Profit Growth | -32.85% |
Log In |
Log In |
Log In |
Log In |
| North America Operating Profit | 140.76M |
Log In |
Log In |
Log In |
Log In |
| North America Operating Profit Growth | -42.40% |
Log In |
Log In |
Log In |
Log In |
| Rest of the World Operating Profit | 1.27M |
Log In |
Log In |
Log In |
Log In |
| Rest of the World Operating Profit Growth | -61.98% |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Operating Profit | -12.61M |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Operating Profit Growth | -118.82% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Italy | 176.52M |
Log In |
Log In |
Log In |
Log In |
| Italy Growth | -17.88% |
Log In |
Log In |
Log In |
Log In |
| Europe | 288.15M |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | -0.20% |
Log In |
Log In |
Log In |
Log In |
| North America | 618.94M |
Log In |
Log In |
Log In |
Log In |
| North America Growth | -11.59% |
Log In |
Log In |
Log In |
Log In |
| Rest of the World | 101.81M |
Log In |
Log In |
Log In |
Log In |
| Rest of the World Growth | -11.70% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Ex-COVID Immunodiagnostics % of Revenue | 66.20 |
Log In |
Log In |
Log In |
Log In |
| Ex-COVID Immunodiagnostics % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In |
| Ex-COVID Molecular Diagnostics % of Revenue | 17.20 |
Log In |
Log In |
Log In |
Log In |
| Ex-COVID Molecular Diagnostics % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In |
| Licensed Technologies % of Revenue | 14.40 |
Log In |
Log In |
Log In |
Log In |
| Licensed Technologies % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In |
| COVID % of Revenue | 2.20 |
Log In |
Log In |
Log In |
Log In |
| COVID % of Revenue Growth | - |
Log In |
Log In |
Log In |
Log In |